DAX24.539 +0,2%Est505.850 +1,0%MSCI World4.343 -0,1%Top 10 Crypto12,09 +4,0%Nas23.194 -0,2%Bitcoin77.057 +2,0%Euro1,1730 -0,1%Öl60,32 -1,0%Gold4.327 +0,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 NVIDIA 918422 DroneShield A2DMAA Deutsche Telekom 555750 Bayer BAY001 Lufthansa 823212 Novo Nordisk A3EU6F Siemens Energy ENER6Y Infineon 623100 BYD A0M4W9 SAP 716460 Allianz 840400 Mercedes-Benz Group (ex Daimler) 710000 RENK RENK73 Tesla A1CX3T
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX geht freundlich ins Wochenende -- Rüstungstitel: Entscheidung über Luftkampfsystem FCAS erneut vertagt -- Goldpreis, Commerzbank, DroneShield, Nike, Stahlaktien im Fokus
Top News
Consorsbank-Depot zu teuer? Mit diesem Broker sparst Du dauerhaft Gebühren Consorsbank-Depot zu teuer? Mit diesem Broker sparst Du dauerhaft Gebühren
Top-News der Woche: Diese Themen waren diese Woche wichtig Top-News der Woche: Diese Themen waren diese Woche wichtig
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Penumbra Aktie

Kaufen
Verkaufen
Penumbra Aktien-Sparplan
260,20 EUR -6,30 EUR -2,36 %
STU
306,25 USD -4,78 USD -1,54 %
BTT
Penumbra jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

Marktkap.10,38 Mrd. EUR

KGV665,58Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKNA14Y65

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS70975L1070

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolPEN

Penumbra Aktien News

DatumMeistgelesen
ZacksHere's Why Penumbra (PEN) is a Strong Growth Stock
PR NewswirePenumbra, Inc. to Present at the 44th Annual J.P. Morgan Healthcare Conference
ZacksReasons to Retain Penumbra Stock in Your Portfolio for Now
Wer­bungPenumbra-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
ZacksHere's Why Penumbra (PEN) is a Strong Growth Stock
BenzingaHere's How Much $1000 Invested In Penumbra 10 Years Ago Would Be Worth Today
ZacksHere's Why Penumbra (PEN) is a Strong Growth Stock
BenzingaHere's How Much You Would Have Made Owning Penumbra Stock In The Last 10 Years
PR NewswirePenumbra, Inc. to Present at the Piper Sandler 37th Annual Healthcare Conference
ZacksWhy Penumbra (PEN) is a Top Momentum Stock for the Long-Term
BenzingaHere's How Much $1000 Invested In Penumbra 10 Years Ago Would Be Worth Today
BenzingaLooking Into Penumbra Inc's Recent Short Interest
ZacksPenumbra Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand
ZacksDo Options Traders Know Something About Penumbra Stock We Don't?
ZacksWhy Penumbra (PEN) is a Top Growth Stock for the Long-Term
BenzingaExpedia, Sandisk and Penumbra Are Among the Top 10 Large-Cap Gainers Last Week (Nov. 3-Nov. 7): Are the Others in Your Portfolio?
MotleyFoolPenumbra (PEN) Q3 2025 Earnings Call Transcript
ZacksPenumbra (PEN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
ZacksPenumbra (PEN) Q3 Earnings and Revenues Beat Estimates
PR NewswirePenumbra, Inc. Reports Third Quarter 2025 Financial Results
BenzingaA Look Into Penumbra Inc's Price Over Earnings
PR NewswireLatest Data from Landmark STORM-PE Randomized Controlled Trial Demonstrate that CAVT with Anticoagulation Significantly Improves Functional Outcomes for Patients with Pulmonary Embolism
PR NewswireLandmark STORM-PE Randomized Controlled Trial Finds Computer Assisted Vacuum Thrombectomy (CAVT) with Anticoagulation Superior to Traditional Anticoagulation Treatment for Pulmonary Embolism
BenzingaDeep Dive Into Penumbra Stock: Analyst Perspectives (13 Ratings)
BenzingaHere's How Much You Would Have Made Owning Penumbra Stock In The Last 10 Years
PR NewswirePenumbra, Inc. Schedules Investor Event at TCT Conference on October 26, 2025; Earnings Release and Conference Call for Third Quarter 2025 Scheduled for November 5, 2025
BenzingaThis Penumbra Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday
Benzinga9 Analysts Assess Penumbra: What You Need To Know
BenzingaA Look Into Penumbra Inc's Price Over Earnings
Benzinga$100 Invested In Penumbra 10 Years Ago Would Be Worth This Much Today
BenzingaPeering Into Penumbra Inc's Recent Short Interest
BenzingaHere's How Much $100 Invested In Penumbra 10 Years Ago Would Be Worth Today
PR NewswireNew Survey Shows Management of Blood Clots is Inconsistent, Even for Patients with the Same Risk Profile
BenzingaDeep Dive Into Penumbra Stock: Analyst Perspectives (9 Ratings)
BenzingaThis Penumbra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
ZacksWhy Is Penumbra (PEN) Up 5% Since Last Earnings Report?
PR NewswirePenumbra, Inc. Names Shruthi Narayan as Company President
PR NewswirePenumbra, Inc. to Present at Upcoming Investor Conferences
MotleyFoolPenumbra PEN Q2 2025 Earnings Call Transcript
BenzingaExpert Outlook: Penumbra Through The Eyes Of 7 Analysts
PR NewswirePenumbra, Inc. to Present at the Canaccord Genuity 45th Annual Growth Conference

Penumbra News

Penumbra News: auf dieser Seite finden Sie alle Penumbra News und Nachrichten zur Penumbra Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Penumbra News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Penumbra News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.